Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients

References

Page 1

	Year	Citations
Statistical Power Analysis for the Behavioral Sciences Keith E. Muller, Jacob Cohen Technometrics Behavioral SciencesStatistical Power AnalysisEngineeringPower IndexPsychometrics	1989	83.9K
Statistical power analysis for the behavioral sciences Computers Environment and Urban Systems Behavioral SciencesStatistical Power AnalysisEngineeringPower IndexPsychometrics	1990	65.6K
Statistical Power Analysis for the Behavioral Sciences (2nd ed.). Peter A. Lachenbruch, Jacob Cohen Journal of the American Statistical Association Statistical Power AnalysisBehavioral SciencesPsychologyPsychometrics	1989	37.5K
Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach Elizabeth R. DeLong, David M. DeLong, Daniel L. Clarke‐Pearson Biometrics EngineeringNew TestsGeneralizability TheoryStatistical FoundationDiagnosis	1988	21.5K
The meaning and use of the area under a receiver operating characteristic (ROC) curve. J A Hanley, Barbara J. McNeil Radiology EngineeringGeneralizability TheoryBiometricsDiagnosisDisease Classification	1982	21.3K
Functional evaluation : Barthel index F. I. Mahonery Medical Entomology and Zoology Information RetrievalEvaluation MeasureBarthel IndexEvaluation TechniqueEconomic Analysis	1965	12.9K
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Michael Herdman, Claire Gudex, Andrew Lloyd, Quality of Life Research	2011	9.2K
Interobserver agreement for the assessment of handicap in stroke patients. John C. van Swieten, Peter J. Koudstaal, Marieke C. Visser, Stroke DisabilityCerebrovascular DiseaseNeurological RehabilitationStroke RehabilitationStroke	1988	6.3K
FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Florence Mahoney, DOROTHEA W. BARTHEL PubMed	1965	5.9K
Quality of life and pharmacoeconomics in clinical trials Joseph L. Pater Controlled Clinical Trials Quality Of LifeHealth PolicyHealth EconomicsClinical TrialsPharmacoeconomics	1996	2.4K

Page 1